Data from EMC - Curated by EPG Health - Last updated 22 August 2016
Indication(s)
- Prostin E2 Sterile Solution 1 mg/ml:
The induction of labour by the intravenous route.
- Prostin E2 Sterile Solution 10 mg/ml:
Oxytocic agent. Therapeutic termination of pregnancy, missed abortion and hydatidiform mole by the intravenous route.
Learning Zones
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
EADV 2018 Highlights
EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.
Chronic Lymphocytic Leukaemia (CLL)
Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more
+ 1 more
Transplantation
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
Atopic Dermatitis
The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.
Anticoagulation Therapy for Stroke Prevention
Anticoagulation therapy for Stroke Prevention Learning Zone offers a deep-dive into atrial fibrillation causes, consequences, diagnosis and management to help you deliver optimal care and prevent strokes in patients living with this common arrhythmia.
Psoriasis Academy
Learn about the burden of psoriasis, unmet needs, the tools used to assess severity and treatment response, what we know about the pathophysiology behind the condition and what the current guidelines say.
+ 1 more
Related Content
Study of IMMU-132 in HR+/HER2- MBC (TROPICS-02)
This is an open-label, randomized, multicenter Phase 3 study to compare the efficacy and safety of Sacituzumab Govitecan versus TPC in subjects with metastatic or locally recurrent inoperable HR+/HER2- MBC, after failure of...
Added 2 months ago
A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) (IMpassion131)
This Phase 3, multicenter, randomized, double-blind, placebo controlled study is designed to evaluate the efficacy and safety of atezolizumab (MPDL3280A, an anti-programmed death-ligand 1 [PD-L1] antibody) administered in...
Added 2 months ago
A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer (IMpassion031)
This is a global Phase III, double-blind, randomized, placebo-controlled study designed to evaluate the efficacy and safety of neoadjuvant treatment with atezolizumab (anti-programmed death-ligand 1 [anti-PD-L1] antibody) and...
Added 2 months ago
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
The purpose of this study is to assess the efficacy and safety of pembrolizumab (MK-3475) versus placebo in combination with neoadjuvant (pre-surgery) chemotherapy and adjuvant (post-surgery) endocrine therapy in the treatment of...
Added 2 months ago
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer (ASCENT)
This is an international, multi-center, open-label, randomized, Phase III study in patients with metastatic TNBC refractory or relapsing after at least 2 prior chemotherapies (including a taxane) for their metastatic disease.
Added 2 months ago
Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
We aimed to measure levels and track trends in maternal mortality, the key causes contributing to maternal death, and timing of maternal death with respect to delivery.
Added 4 months ago
Haemostasis in normal and abnormal pregnancy.
Haemostasis is a complex and dynamic equilibrium involving pro-coagulants, the natural anticoagulation system and fibrinolysis. Normal human pregnancy is associated with profound alterations to the process of haemostasis such...
Added 4 months ago
Pre-anaesthetic assessment of coagulation abnormalities in obstetric patients: usefulness, timing and clinical implications.
The usefulness and optimal timing of laboratory coagulation tests before obstetric extradural analgesia are controversial. Moreover, the significance of mild coagulation abnormalities during pregnancy remains unclear.
Added 4 months ago
Haematological and fibrinolytic status of Nigerian women with post-partum haemorrhage.
Background: Early treatment with tranexamic acid reduces deaths due to bleeding after post-partum haemorrhage. We report the prevalence of haematological, coagulation and fibrinolytic abnormalities in Nigerian women with...
Added 4 months ago
Predelivery maternal fibrinogen as a predictor of blood loss after vaginal delivery.
Purpose: The present study investigated whether fibrinogen level during the first stage of labor is associated with bleeding severity in the third stage of labor.
Added 4 months ago
Intrapartum care for women with existing medical conditions or obstetric complications and their babies
This guideline covers care during labour and birth for women who need extra support because they have a medical condition or complications in their current or previous pregnancy. The guideline also covers women who have had no...
Added 2 months ago
Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium
The aim of this guideline is to provide advice, based on clinical evidence where available, regarding the prevention of venous thromboembolism (VTE) during pregnancy, birth and following delivery.
Added 4 years ago
Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management
The aim of this guideline is to provide information, based on clinical evidence where available, regarding the immediate investigation and...
Added 4 years ago
The Management of Women with Red Cell Antibodies during Pregnancy
The purpose of this guideline is to provide guidance on the management of pregnant women with red cell antibodies predating the pregnancy or those developing antibodies during pregnancy.
Added 5 years ago
More information
| Category | Value |
|---|---|
| Orphan designation | No |
| Type | POM |
| Marketing authorisation holder | Pfizer Limited |